Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
YMAB

YMAB - Y-mAbs Therapeutics Inc Stock Price, Fair Value and News

11.58USD-0.12 (-1.03%)Delayed

Latest Insider Trading transactions for YMAB

Datesorted ascendingNameBuy/Sell$ Value# SharesAvg. PriceTitle
2024-07-12 Premium
acquired
Premium Premium PremiumCFO and Treasurer
2024-06-11 Premium
acquired
Premium Premium Premium-
2024-06-11 Premium
acquired
Premium Premium Premium-
2024-06-11 Premium
acquired
Premium Premium Premium-
2024-06-11 Premium
acquired
Premium Premium Premium-
2024-06-11 Premium
acquired
Premium Premium Premium-
2024-06-11 Premium
acquired
Premium Premium Premium-
2024-06-11 Premium
sold
Premium Premium PremiumCHIEF BUSINESS OFFICER
2024-06-10 Premium
sold
Premium Premium PremiumCHIEF BUSINESS OFFICER
2024-06-10 Premium
sold
Premium Premium Premium-
2024-05-31 Premium
sold
Premium Premium PremiumEVP, CFO, SECRY & TREAS.
2024-05-31 Premium
acquired
Premium Premium PremiumEVP, CFO, SECRY & TREAS.
2024-05-30 Premium
sold
Premium Premium PremiumEVP, CFO, SECRY & TREAS.
2024-05-30 Premium
acquired
Premium Premium PremiumEVP, CFO, SECRY & TREAS.
2024-05-23 Premium
sold
Premium Premium PremiumCHIEF BUSINESS OFFICER
2024-05-21 Premium
sold
Premium Premium PremiumCHIEF BUSINESS OFFICER
2024-03-12 Premium
acquired
Premium Premium Premium-
2024-03-05 Premium
sold
Premium Premium PremiumSVP & CHIEF COMMERCIAL OFFICER
2024-03-05 Premium
sold
Premium Premium PremiumCHIEF BUSINESS OFFICER
2024-03-05 Premium
sold
Premium Premium PremiumSVP & CHIEF MEDICAL OFFICER
2024-02-12 Premium
acquired
Premium Premium PremiumPRESIDENT & CEO
2024-01-18 Premium
acquired
Premium Premium PremiumEVP, CFO, SECRY & TREAS.
2024-01-18 Premium
acquired
Premium Premium PremiumSVP & CHIEF OPERATING OFFICER
2024-01-18 Premium
acquired
Premium Premium PremiumSVP & CHIEF SCIENTIFIC OFFICER
2024-01-18 Premium
acquired
Premium Premium PremiumSVP & CHIEF COMMERCIAL OFFICER

Rows per page:

1–25 of 50